MINM yields 55.40% · JNJ yields 2.14%● Live data
📍 MINM pulled ahead of the other in Year 1
Combined, MINM + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MINM + JNJ for your $10,000?
Minim, Inc., together with its subsidiaries, designs, develops, sells, and supports an Internet of Things security platform in North America and internationally. It offers hardware products, including cable modems, cable modem/routers, gateways, mobile broadband modems, wireless routers, multimedia over coax adapters, mesh home networking devices, and other local area network products. The company also provides Minim mobile applications for end users to personalize and monitor their home and office network for speed testing, data usage tracking, security alerts, malware blocking, privacy settings, and parental controls; and Minim web application that enables technical support representatives of Internet Service Providers (ISPs) and businesses to offer remote support with network insights. In addition, it offers Minim API suite and MinimOS for third-party hardware vendors, ISPs, and other partners to integrate with the Minim platform and functionality; to manage their own account data; and to integrate with third-party router firmware. The company offers its products under the ZOOM, Motorola, and Minim brands. It sells its products through direct sales force and commissioned independent sales representatives to retailers; and retailers, distributors, ISPs, individual businesses, service providers, value-added resellers, PC system integrators, original equipment manufacturers, channel resellers, electronics distributors, and e-commerce platforms. The company was formerly known as ZoomTelephonics, Inc. and changed its name to Minim, Inc. in June 2021. Minim, Inc. was incorporated in 1977 and is headquartered in Manchester, New Hampshire.
Full MINM Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.